520 related articles for article (PubMed ID: 17507813)
1. Diffusion tensor magnetic resonance imaging of prostate cancer.
Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
[TBL] [Abstract][Full Text] [Related]
2. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy.
Takayama Y; Kishimoto R; Hanaoka S; Nonaka H; Kandatsu S; Tsuji H; Tsujii H; Ikehira H; Obata T
J Magn Reson Imaging; 2008 Jun; 27(6):1331-5. PubMed ID: 18504751
[TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor imaging of prostate at 3.0 Tesla.
Li C; Chen M; Li S; Zhao X; Zhang C; Liu M; Zhou C
Acta Radiol; 2011 Sep; 52(7):813-7. PubMed ID: 21586608
[TBL] [Abstract][Full Text] [Related]
4. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T.
Pickles MD; Gibbs P; Sreenivas M; Turnbull LW
J Magn Reson Imaging; 2006 Feb; 23(2):130-4. PubMed ID: 16374882
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
8. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.
Zelhof B; Pickles M; Liney G; Gibbs P; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Apr; 103(7):883-8. PubMed ID: 19007373
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
10. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade.
Tamada T; Sone T; Jo Y; Toshimitsu S; Yamashita T; Yamamoto A; Tanimoto D; Ito K
J Magn Reson Imaging; 2008 Sep; 28(3):720-6. PubMed ID: 18777532
[TBL] [Abstract][Full Text] [Related]
11. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
Gibbs P; Liney GP; Pickles MD; Zelhof B; Rodrigues G; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
13. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
[TBL] [Abstract][Full Text] [Related]
14. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor imaging (DTI) of the kidney at 3 tesla-feasibility, protocol evaluation and comparison to 1.5 Tesla.
Notohamiprodjo M; Dietrich O; Horger W; Horng A; Helck AD; Herrmann KA; Reiser MF; Glaser C
Invest Radiol; 2010 May; 45(5):245-54. PubMed ID: 20375845
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
[TBL] [Abstract][Full Text] [Related]
17. Potential of diffusion tensor MRI in the assessment of periventricular leukomalacia.
Fan GG; Yu B; Quan SM; Sun BH; Guo QY
Clin Radiol; 2006 Apr; 61(4):358-64. PubMed ID: 16546466
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences.
Kozlowski P; Chang SD; Goldenberg SL
Magn Reson Imaging; 2008 Jan; 26(1):72-6. PubMed ID: 17566687
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
20. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
